Frontlight ResearchEarly access
Trial site
Pudong New Area People's Hospital Shanghai
- 3running trials
- 4closed trials
The trials here
What the 7 trials at this site are about, from their registry records.
- Conditions
- Type 2 diabetes3 trials
- Alzheimer disease2 trials
- Obesity2 trials
- Obstructive sleep apnoea1 trial
- Phase
- Phase 37 trials
- Status
- Completed4 trials
- Recruiting2 trials
- Active, not recruiting1 trial
- Lead sponsor
- Eli Lilly and Company6 trials
- Pfizer1 trial
Running trials
Recruiting
Recruiting
Active, not recruiting
A Study of Remternetug (LY3372993) in Early Alzheimer's Disease (TRAILRUNNER-ALZ 3)
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Alzheimer disease1 recruiting
- Obesity1 recruiting
Closed trials
Completed
Completed
Completed
A Study of Tirzepatide (LY3298176) in Chinese Participants With Type 2 Diabetes (SURPASS-CN-MONO)
Completed
Site data: ClinicalTrials.govUpdated 12 Nov 2026